All sponsors

Avistone Biotechnology Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-32
RECRUITING4
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO60%

Delay Index: of 5 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +10.2 months). See all sponsors →

Open Avistone Biotechnology Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
KANNON
NCT06015503
P2Active, not recruitingNSCLC (Non-small Cell Lung Cancer)1392025-03-06 (+10 mo)
KYLIN-2
NCT06574347
P2RecruitingNon-Small-Cell Lung Cancer1202026-10-31
KANNON-5
NCT07336732
P2RecruitingNon-Small-Cell Lung Cancer402026-11
KYLIN-1
NCT06343064
P1/2RecruitingNon-Small-Cell Lung Cancer1562026-12-31 (+24 mo)
KYLIN-3
NCT06970782
P3Not yet recruitingNon-Small-Cell Lung Cancer2782027-12-31
KANNON-2
NCT06281964
P3Enrolling by invitationNon-Small-Cell Lung Cancer3272028-06-30 (+29 mo)
ANS02
NCT07538804
P1/2RecruitingNon-Small Cell Lung Cancer2942029-06-30